| Ident. | Authors (with country if any) | Title |
|---|
| 002A63 |
Thierry Andre [France, Italie, Espagne, Royaume-Uni, Australie] ; Corrado Boni ; Matilde Navarro ; Josep Tabernero ; Tamas Hickish ; Clare Topham ; Andrea Bonetti ; Philip Clingan ; John Bridgewater ; Fernando Rivera ; Aimery De Gramont | Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial |
| 004A20 |
Thierry Andre [France] ; Corrado Boni [Italie] ; Lamia Mounedji-Boudiaf [France] ; Matilde Navarro [Espagne] ; Josep Tabernero [Espagne] ; Tamas Hickish [Royaume-Uni] ; Clare Topham [Royaume-Uni] ; Marta Zaninelli [Italie] ; Philip Clingan [Australie] ; John Bridgewater [Royaume-Uni] ; Isabelle Tabah-Fisch [France] ; Aimery De Gramont [France] | Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer |
| 005674 |
Henning Mouridsen [Danemark, Russie, République populaire de Chine, Espagne, Italie, France, Afrique du Sud, États-Unis, Pays-Bas, Allemagne, Pologne, Hongrie, Belgique, Inde, Finlande, Australie, Suisse] ; Mikhail Gershanovich ; YAN SUN ; Ramon Perez-Carrion ; Corrado Boni ; Alain Monnier ; Justus Apffelstaedt ; Robert Smith ; Harm P. Sleeboom ; Fritz J Nicke ; Anna Pluzanska ; Magdolna Dank ; Dominique Becquart ; Poonamalle P. Bapsy ; Eeva Salminen ; Ray Snyder ; Mercedes Lassus ; J. Arnold Verbeek ; Beatrix Staffler ; Hilary A. Chaudri-Ross ; Margaret Dugan | Superior efficacy of Letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group |
